Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 12,582	$ 5,224	$ 23,932	$ 9,022
General and administrative	4,892	3,211	9,942	5,270
Total operating expenses	17,474	8,435	33,874	14,292
Loss from operations	(17,474)	(8,435)	(33,874)	(14,292)
Interest and other income (expense), net	216	36	250	41
Net loss	(17,258)	(8,399)	(33,624)	(14,251)
Other comprehensive loss:
Unrealized gain (loss) on investments, net	6	17	(7)	2
Comprehensive loss	$ (17,252)	$ (8,382)	$ (33,631)	$ (14,249)
Net loss per common share, basic and diluted	$ (0.59)	$ (0.33)	$ (1.15)	$ (0.77)
Weighted-average number of common shares used to compute basic and diluted net loss per common share	29,196,398	25,161,038	29,161,437	18,598,521